Health Tech
Health tech and digital health are transforming the health sector and creating unprecedented opportunities
Today’s demands of a fluid, fast-paced technology industry, mean that businesses must remain technologically and operationally agile in order to survive and thrive in a hugely ambitious and competitive environment. Whilst we are seeing more and more disruptive technologies transforming the health care industry and presenting more opportunities, we are also witnessing many more challenges, while coping with problem that the law is often a few steps behind the latest technological development.
Our specialist lawyers, many of whom have spent time as in-house counsel for technology companies, are passionate about the opportunities and challenges faced by our clients at all stages of their life cycle. We can offer practical and realistic solutions to your transactional and protection requirements, and take a hands-on approach to disputes relating to rights infringements or breach of commercial contracts.
We can advise on:
- Corporate
- IP, copyright and trademark
- Cloud computing
- Data protection and privacy
- E-commerce and online trading
- Hardware
- Information technology services
- Licensing
- Outsourcing
- Procurement
- Social media
- Software
We have advised many health tech companies that are listed on the Main Market and AIM of the London Stock Exchange, including EKF Diagnostics, Novacyt, Summit Therapeutics, Trellus Health, Verici Dx, Source Bioscience and Renalytix AI.
AIM Timeline
Our corporate team has advised on over 10 transactions in the health tech sector for AIM listed companies, including five IPOs. You can see details of some of these in our AIM deal timeline here:
Corporate analysis carried out by LexisNexis UK reviewing IPO deal activity in the first half of 2021 has revealed that we are one of the firms instructed on the most deals in H1 2021.
In July 2021, we were ranked 3rd by the number of Health Care clients in Adviser Rankings’ Q3 Advisers Rankings Guide.
BUIDLING BETTER CASE STUDY
NOVACYT First Covid Test
Revenues at Novacyt increased by more than 20 times after the COVID-19 tests that they manufacture were one of the world’s first to be approved. The AIM-listed diagnostics company is listed in London and Paris and has a head office in Camberley, Surrey.
""always available and strong on both detail and giving advice...has advised on some difficult transactions but his team always perform
